静脉-静脉体外膜氧合预后评分系统临床应用的研究进展  

Research progress on the clinical application of veno-venous extracorporeal membrane oxygenation prognostic scoring systems

作　　者：路思捷 李慧珍 李勇男[2] 吴向阳[2] Lu Sijie;Li Huizhen;Li Yongnan;Wu Xiangyang(Department of Cardiac Surgery,the Second Hospital&Clinical Medical School,Lanzhou University,Gansu Lanzhou 730030,China)

机构地区：[1]兰州大学第二临床医学院,兰州700030 [2]兰州大学第二医院心脏外科

出　　处：《中国体外循环杂志》2025年第2期170-175,共6页Chinese Journal of Extracorporeal Circulation

基　　金：甘肃省科技计划项目(23JRRA1502)。

摘　　要：静脉-静脉体外膜氧合(V-V ECMO)是一种用于治疗严重呼吸衰竭的高级生命支持技术,适用于那些对常规治疗无效的重度急性呼吸窘迫综合征(ARDS)患者以及其他需要临时呼吸支持的患者。及时识别接受V-V ECMO治疗患者的死亡危险因素,并全面分析幸存者的长期预后是至关重要的。目前,对严重ARDS行V-V ECMO的死亡预测(PRESERVE)评分、呼吸ECMO生存预测(RESP)评分、ECMO协作网络(ECMOnet)评分以及危重症评分包括序贯器官衰竭评分(SOFA)、简化急性生理学评分(SAPS II)、急性生理和慢性健康(APACHE)评分等广泛应用于V-V ECMO患者的评估。本综述系统总结现有的V-V ECMO预后评分系统,有助于辅助临床医生更准确地评估危重患者、合理选择恰当的ECMO干预时机,从而减少不必要的医疗资源消耗,提高患者的存活率及生活质量。Veno-venous extracorporeal membrane oxygenation(V-V ECMO)is an advanced life support technique employed in the management of severe respiratory failure,particularly in patients with severe acute respiratory distress syndrome(ARDS)who have not responded to conventional therapies,as well as in other conditions requiring temporary respiratory support.Identifying mortality risk factors and comprehensively analyzing the long-term prognosis of V-V ECMO patients are critical.Currently,various prognostic scoring systems are widely applied for V-V ECMO assessment,including the PRESERVE score,RESP score,ECMOnet score,and critical illness scoring systems such as the SOFA,SAPS II,and APACHE scores.This review systematically summarizes the existing prognostic scoring systems for V-V ECMO,aiming to assist clinicians in accurately assessing critically ill patients,optimizing ECMO intervention timing,reducing unnecessary resource consumption,and ultimately improving survival rates and quality of life in these patients.

关 键 词：体外膜氧合 体外生命支持 预后评分系统 危重症 重症监护 急性呼吸窘迫综合征 

分 类 号：R563.8[医药卫生—呼吸系统]